Acacia Research Corporation (ACTG) 13D/13G Filings for Theravance Biopharma, Inc. (TBPH)

Acacia Research Corporation 13D and 13G filings for Theravance Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-06-11
11:43 am
Unchanged		 2020-06-04 13G Theravance Biopharma, Inc.
TBPH		 ACACIA RESEARCH CORP
ACTG		 0
0.000%		 0
(Unchanged)		 Filing